TCF7L1 regulates cytokine response and neuroendocrine differentiation of prostate cancer

Yu-Ching Wen1,2,3, Yen-Nien Liu4, Hsiu-Lien Yeh5

  • 1Department of Urology, Wan Fang Hospital, Taipei Medical University, Taipei, Taiwan.

Oncogenesis
|November 20, 2021
PubMed

Insights

Androgen-deprivation therapy failure in prostate cancer activates WNT4/TCF7L1 signaling, increasing Interleukin-8/CXCR2 expression. This promotes neuroendocrine differentiation and malignancy, driving prostate cancer progression.

Area of Science:

  • Oncology
  • Molecular Biology
  • Urology

Background:

  • Neuroendocrine differentiation (NED) in prostate cancer is linked to WNT signaling activation, particularly after androgen-deprivation therapy (ADT) failure.
  • The precise mechanisms by which ADT-induced WNT signaling promotes cytokine signaling and contributes to NED remain unclear.

Purpose of the Study:

  • To elucidate the role of ADT-upregulated WNT signaling in activating cytokine signaling and driving prostate cancer NED.
  • To identify key molecular players involved in the transition to a neuroendocrine phenotype following ADT.

Main Methods:

  • Investigated the expression and function of transcription factor 7 like 1 (TCF7L1) in prostate cancer cells under ADT conditions.
  • Analyzed the impact of WNT4 and TCF7L1 on Interleukin-8 (IL-8) and CXCR2 expression.
  • Examined the binding of TCF7L1 to regulatory regions of IL-8 and CXCR2.
  • Assessed TCF7L1 and CXCR2 levels in clinical samples of small-cell prostate cancer and castration-resistant prostate cancer.

Main Results:

  • ADT upregulates TCF7L1, which enhances cytokine response and promotes NED via IL-8/CXCR2 signaling.
  • ADT induces WNT4 secretion, leading to TCF7L1 engagement and increased IL-8 and CXCR2 expression.
  • TCF7L1 directly binds to IL-8 and CXCR2 regulatory regions, upregulating IL-8/CXCR2-driven NED and cell motility.
  • Clinical samples show increased nuclear TCF7L1 and CXCR2 in neuroendocrine and castration-resistant prostate cancer.

Conclusions:

  • WNT4/TCF7L1 induction drives NED and malignancy in prostate cancer by dysregulating androgen receptor signaling and activating the IL-8/CXCR2 pathway.
  • Targeting the WNT4/TCF7L1/IL-8/CXCR2 axis may offer therapeutic strategies for advanced prostate cancer.

Related Concept Videos

TGF - β Signaling Pathway01:16

TGF - β Signaling Pathway

The TGF-β signaling pathway regulates cell growth, differentiation, adhesion, motility, and development. TGF-β ligands that induce TGF-β signaling are synthesized in their latent form. Several proteases or cell surface receptors such as integrins act upon the latent form, releasing the active ligand. There are three types of mammalian TGF-βs: (TGF-β1, TGF-β2, and TGF-β3) that bind as homodimers or heterodimers to TGF-β receptors. The TGF-β receptors...
8.0K
Receptor Downregulation in MVBs01:15

Receptor Downregulation in MVBs

Multivesicular bodies (MVBs) are mature endosomes that sort ubiquitinated proteins and then fuse with lysosomes to degrade the sorted proteins. Epidermal growth factor (EGF) and its receptor (EGFR) form a complex that can be internalized through endocytosis, sorted into an MVB, and later degraded.
The EGFR can initiate signaling pathways that  lead to cell proliferation, migration, and differentiation. Overexpression of EGFR  stimulates cells to proliferate. Excessive  EGFR...
2.3K
T Cell Types and Functions01:24

T Cell Types and Functions

When T cells with CD4 markers are activated, they give rise to two types of effector cells: helper T cells and regulatory T cells. Meanwhile, T cells with CD8 markers differentiate into effector cytotoxic T cells. The differentiation of CD4 T cells into helper T cell subsets, such as Th1, Th2, and Th17 cells, is dependent on the antigen type, antigen-presenting cell, and regulatory cytokines.
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
1.5K
Master Transcription Regulators02:23

Master Transcription Regulators

Master transcription regulators are regulatory proteins that are predominantly responsible for regulating the expression of multiple genes. Often these genes work in concert to drive a  complex process. Activation of a master transcription regulator can lead to a cascade of transcriptional activation necessary for that outcome. These regulators can directly bind to the regulatory sequences of the various genes involved, or they can indirectly regulate transcription by binding to regulatory...
7.2K
The Tumor Microenvironment02:17

The Tumor Microenvironment

Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
7.0K
Regulation of Angiogenesis and Blood Supply01:24

Regulation of Angiogenesis and Blood Supply

Rapidly dividing tumors, embryos, and wounded tissues require more oxygen than usual, lowering the oxygen concentration in the blood. At low oxygen or hypoxic conditions, an oxygen-sensitive transcription factor called the hypoxia-inducible factor 1 or HIF1 is activated. HIF1 is a dimeric protein of alpha (ɑ) and beta (β) subunits.  Under optimal oxygen conditions, HIF1β is present in the nucleus while HIF1ɑ remains in the cytosol. HIF1ɑ is hydroxylated by prolyl...
2.9K